CN Patent
CN104688680A — 包含匹莫苯与环糊精的复合物的液体制剂
Assigned to Boehringer Ingelheim Vetmedica GmbH · Expires 2015-06-10 · 11y expired
What this patent protects
本发明涉及新的液体制剂,其包含取代的苯并咪唑(优选为匹莫苯)作为药物活性化合物。具体地,本发明涉及液体制剂,其包含醚化的环糊精衍生物(优选以约20%至70%(w/v)浓度)和所述的取代的苯并咪唑(优选以约0.005%至0.15%(w/w)浓度)。
USPTO Abstract
本发明涉及新的液体制剂,其包含取代的苯并咪唑(优选为匹莫苯)作为药物活性化合物。具体地,本发明涉及液体制剂,其包含醚化的环糊精衍生物(优选以约20%至70%(w/v)浓度)和所述的取代的苯并咪唑(优选以约0.005%至0.15%(w/w)浓度)。
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.